THE ROLE OF DOCETAXEL AS FIRST-LINE CHEMOTHERAPY ON PSA LEVEL AND QOL IN CRPC PATIENTS
Objective: Prostate cancer is the second most common cancer in men and the fifth leading cause of death worldwide. 10-20% of cases can progress to a more aggressive stage called castration-resistant prostate cancer (CRPC) with a higher death rate. Clinical guidelines recommend docetaxel as first-li...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
IKATAN AHLI UROLOGI INDONESIA
2024-05-01
|
| coleção: | Jurnal Urologi Indonesia |
| Assuntos: | |
| Acesso em linha: | https://juri.urologi.or.id/juri/article/view/853 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|